Market Overview The US anti radiation drugs market is diversifying into oncology as cancer centers adopt radioprotectants to improve patient tolerance and treatment completion rates. The US Anti Radiation Drugs Market is projected to grow through 2030, driven by increasing radiation therapy utilization, growing emphasis on quality-of-life preservation during curative treatment, rising head and...